MIR4743

Across TCGA pan-cancer cohorts, MIR4743 RNA is linked to patient survival in 4 of 34 cancer types, making it the most broadly survival-associated MIR4743 data layer.

The strongest signal is observed in cholangiocarcinoma (CHOL), where higher MIR4743 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated MIR4743 expression acts as an unfavorable survival marker, although some lineages such as LAML show a favorable association.

CHOL, LUSC, and LAML are the cancer types where MIR4743 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
CHOL	OS	Tertile	All	0.024	0.728	<.001	108	view →
LUSC	OS	Tertile	All	0.210	0.765	<.001	36	view →
LAML	DFS	Tertile	All	0.540	0.309	.005	34	view →
MESO	OS	Tertile	II,III,IV	0.180	0.560	.046	9	view →

Pink = unfavorable, green = favorable. Showing the 4 strongest of 4 lineages.

MIR4743–CHOL (OS)

Open the CHOL breakdown →